Is IRIX's earnings trend improving for investors?

**IRIX's earnings trend is showing signs of improvement for investors**, as evidenced by the following points: 1. **Revenue Growth**: Iridex reported a year-over-year revenue growth of 1.91% in Q4 2024, with total revenue increasing to $12.7 million. This indicates a positive trend in the company's sales performance. 2. **Gross Margin Improvement**: The gross margin for Q4 2024 increased to 44.0%, up from 39.2% in the same period last year. This suggests that Iridex is becoming more efficient in managing its production costs relative to its sales. 3. **Adjusted EBITDA Positive**: Iridex achieved positive adjusted EBITDA for the first time in recent history, with $0.4 million in Q4 2024, an improvement of $2.4 million compared to the prior year. This is a significant indicator of improved financial health and cash flow generation. 4. **Strategic Investments**: The company secured $10 million in gross proceeds from a strategic investment, with potential for an additional $10 million for future growth initiatives. This strategic move is likely to bolster Iridex's financial position and support its business expansion. 5. **Stock Performance**: Following the earnings release, Iridex's stock experienced a notable surge of 13.04% in aftermarket trading, closing at $0.998. This positive market reaction suggests that investors are responding favorably to the company's improved earnings outlook. In conclusion, Iridex's recent financial performance and strategic initiatives indicate a trend of improving earnings for investors. The company's revenue growth, gross margin improvement, positive EBITDA, and successful strategic investments all point to a more favorable financial outlook.